Table 1

Description of included studies

NModal trial completion or article publication yearAverage (median) number of publications per trial*Average years from trial completion to article publicationAverage (median) trial length in weeksMaximum trial length in weeksNumber of drug-treated participants (% as reported in summaries)Total number participants
Aripiprazole
 Trial summary2820060.62 (1)2.620.8 (8)14058099935
 Journal article28200910.7 (8)525696 (98)9728
 Unpublished trial summary†21200329.9 (26)9468968112
Olanzapine
 Trial summary3320001.78 (1)2.726.5 (24)78851512 136
 Journal article33200216.8 (6)788225 (97)11 932
 Unpublished trial summary18200518.7 (19)4831204997
Ziprasidone
 Trial summary820050.79 (0)3.817.1 (12)609101399
 Journal article8200710.5 (10)27910 (100) 1399
 Unpublished trial summary21200838.4 (12)32032684459
Atomoxetine
 Trial summary3120051.76 (1)2.235.9 (18)18143137094
 Journal article31200716.7 (10)974138 (96)6975
 Unpublished trial summary20200635.7 (24)10436404469
Duloxetine
 Trial summary3520054.69 (3)227.1 (13)10314 18518 334
 Journal article35200722.8 (13)10314 185 (100)18 334
 Unpublished trial summary13200424.2 (15)6221153413
Sertraline
 Trial summary720031.53 (1)2.937.7 (22)12821472326
 Journal article7200522.9 (22)522147 (100)2326
 Unpublished trial summary9200115.4 (10)3610451541
All Drugs
 Trial summary14220052 (1)2.527.8 (12)18135 87951 224
 Journal article142200716.7 (11)10335 269 (98)50 694
 Unpublished trial summary102200628.8 (16)32020 08426 992
  • *Average and median number of publications reflect all publications listed on the trial summary cover page, including stand-alone journal articles, meta-analyses, subset analyses and conference abstracts.

  • †Unpublished trial summary refers to clinical trial summaries posted on the publicly accessible clinicalstudyresults.org website, but having no associated stand-alone journal article.